Updates on the Treatment of Estrogen Receptor (ER) Positive, Progesterone Receptor (PR) Positive & HER2 Positive Breast Cancer from the 43rd Annual San Antonio Breast Cancer Symposium (SABCS)

Listen Now

Topics Covered

• What’s New from SABCS on: ER, PR and HER2 Positive Breast Cancer, in the Context of COVID-19
• Updates from SABCS on Diagnostic Testing, Precision Medicine, Grade & Hormone Receptors
• What’s New in the Standard of Care
• Updates from SABCS on: Hormone & Targeted Therapy
• Chemotherapy Updates from SABCS
• Investigational New Drugs in Clinical Trials
• What’s New in Prevention & Management of Treatment Side Effects & Long Term Effects
• The Increasing Role of Telemedicine/Telehealth Appointments
• Proper Preparation for the Telemedicine/Telehealth Appointments
• Key Questions from SABCS to Ask Your Healthcare Team about Quality-of-Life Concerns
• Questions for Our Panel of Experts

Our Panel of Experts

Julie R. Gralow, MD

Jill Bennett Endowed Professorship in Breast Cancer, Director, Breast Medical Oncology, University of Washington School of Medicine, Director, Breast Medical Oncology, Seattle Cancer Care Alliance

Generosa Grana, MD, FACP

Medical Director, MD Anderson Cancer Center at Cooper, Division Head, Hematology & Medical Oncology, The Cooper Health System, Professor of Medicine, Cooper Medical School at Rowan University

Sara M. Tolaney, MD, MPH

Associate Director, Susan F. Smith Center for Women’s Cancers, Director, Clinical Trials, Breast Oncology, Senior Physician, Dana-Farber Cancer Institute, Assistant Professor of Medicine, Harvard Medical School

Lauren Chatalian, MSW

Women & Children’s Program Manager, CancerCare

Brochure

You can download the brochure for this workshop

Workshop Date

This workshop was originally recorded on January 13, 2021.